Current Closing Date for Applications: Oct 01, 2007
The Division of Mathematical Sciences in the Directorate for Mathematical and Physical Sciences and the National Institute of General Medical Sciences at the National Institutes of Health plan to support research in mathematics and statistics related to mathematical biology research. Both agencies recognize the need and urgency for additional research at the boundary between the mathematical sciences and the life sciences. This competition is designed to encourage new collaborations at this interface, as well as to support existing ones.
Link to Full Announcement
NSF Publication 06-607
If you have difficulty accessing the full announcement electronically, please contact: Grants.gov support Grants.gov support
Synopsis Modification History
The following files represent the modifications to this synopsis with the changes noted within the documents. The list of files is arranged from newest to oldest with the newest file representing the current synopsis. Changed sections from the previous document are shown in a light grey background.
Original Synopsis
Sep 15, 2006
Monday, July 9, 2007
Clinical Studies of Safety and Effectiveness of Orphan Products
Original Closing Date for Applications:
Feb 06, 2008 All Applications must be received by the close of business on the establised receipt date. The Application Receipt Date is February 6, 2008.
Background OPD was created to identify and promote the development of orphan products. Orphan products are drugs, biologics, medical devices, and foods for medical purposes that are indicated for a rare disease or condition (that is, one with a prevalence, not incidence, of fewer than 200,000 people in the United States). Diagnostic tests and vaccines will qualify only if the U.S. population of intended use is fewer than 200,000 people a year. Additional information about OPD is available on FDA’s Web site at www.fda.gov/orphan. 2. Program Research Goals The goal of FDA’s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product will improve the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application’s ‘‘Background and Significance’’ section documentation to support the estimated prevalence of the orphan disease or condition and an explanation of how the proposed study will either help gain product approval or provide essential data needed for product development. All funded studies are subject to the requirements of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 331 et seq.), regulations issued under it, and applicable Department of Health and Human Services (HHS) statutes and regulations. Inclusion of Women And Minorities in Clinical Research Applicants for PHS clinical research grants are encouraged to include minorities and women in study populations so research findings can be of benefit to all people at risk of the disease or condition under study. It is recommended that applicants place special emphasis on including minorities and women in studies of diseases, disorders, and conditions that disproportionately affect them. This policy applies to research subjects of all ages. If women or minorities are excluded or poorly represented in clinical research, the applicant should provide a clear and compelling rationale that shows inclusion is inappropriate. Inclusion of Children as Participants in Clinical Research. FDA regulations at 21 CFR part 50, subpart D contain additional requirements that must be met by IRBs reviewing clinical investigations regulated by FDA and involving children as subjects. FDA is part of HHS; accordingly, the research project grants under this program are supported by HHS, and HHS regulations at 45 CFR part 46, subpart D also apply to research involving children as subjects. Standards for Privacy of Individually Identifiable Health Information HHS issued final modification to the ‘‘Standards for Privacy of Individually Identifiable Health Information,’’ the ‘‘Privacy Rule,’’ on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the HHS Office for Civil Rights (OCR). PHS is committed to achieving the health promotion and disease prevention objectives of ‘‘Healthy People 2010,’’ a PHS-led national activity for setting priority areas. This Funding Opportunity Announcement is related to one or more of the priority areas. Potential applicants may obtain a copy of ‘‘Healthy People 2010’’ at http:// www.health.gov/healthypeople. Smoke-Free Workplace The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103–227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Link to Full Announcement
http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/pdf/E7-12881.pdf
If you have difficulty accessing the full announcement electronically, please contact:
Marc Pitts Senior Grants Management Specialist Phone 301-827-7162 Marc.Pitts@FDA.HHS.GOV
Feb 06, 2008 All Applications must be received by the close of business on the establised receipt date. The Application Receipt Date is February 6, 2008.
Background OPD was created to identify and promote the development of orphan products. Orphan products are drugs, biologics, medical devices, and foods for medical purposes that are indicated for a rare disease or condition (that is, one with a prevalence, not incidence, of fewer than 200,000 people in the United States). Diagnostic tests and vaccines will qualify only if the U.S. population of intended use is fewer than 200,000 people a year. Additional information about OPD is available on FDA’s Web site at www.fda.gov/orphan. 2. Program Research Goals The goal of FDA’s OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product will improve the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application’s ‘‘Background and Significance’’ section documentation to support the estimated prevalence of the orphan disease or condition and an explanation of how the proposed study will either help gain product approval or provide essential data needed for product development. All funded studies are subject to the requirements of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 331 et seq.), regulations issued under it, and applicable Department of Health and Human Services (HHS) statutes and regulations. Inclusion of Women And Minorities in Clinical Research Applicants for PHS clinical research grants are encouraged to include minorities and women in study populations so research findings can be of benefit to all people at risk of the disease or condition under study. It is recommended that applicants place special emphasis on including minorities and women in studies of diseases, disorders, and conditions that disproportionately affect them. This policy applies to research subjects of all ages. If women or minorities are excluded or poorly represented in clinical research, the applicant should provide a clear and compelling rationale that shows inclusion is inappropriate. Inclusion of Children as Participants in Clinical Research. FDA regulations at 21 CFR part 50, subpart D contain additional requirements that must be met by IRBs reviewing clinical investigations regulated by FDA and involving children as subjects. FDA is part of HHS; accordingly, the research project grants under this program are supported by HHS, and HHS regulations at 45 CFR part 46, subpart D also apply to research involving children as subjects. Standards for Privacy of Individually Identifiable Health Information HHS issued final modification to the ‘‘Standards for Privacy of Individually Identifiable Health Information,’’ the ‘‘Privacy Rule,’’ on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the HHS Office for Civil Rights (OCR). PHS is committed to achieving the health promotion and disease prevention objectives of ‘‘Healthy People 2010,’’ a PHS-led national activity for setting priority areas. This Funding Opportunity Announcement is related to one or more of the priority areas. Potential applicants may obtain a copy of ‘‘Healthy People 2010’’ at http:// www.health.gov/healthypeople. Smoke-Free Workplace The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103–227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Link to Full Announcement
http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/pdf/E7-12881.pdf
If you have difficulty accessing the full announcement electronically, please contact:
Marc Pitts Senior Grants Management Specialist Phone 301-827-7162 Marc.Pitts@FDA.HHS.GOV
Friday, July 6, 2007
IMHR 4th Annual Request for Reseach Grant Application
APPLICATION RECEIPT DATE: Application Deadline: September 4, 2007
PURPOSE: The Institute for Mental Health Research invites applications for pilot studies to support basic science and clinical research on mental disorders and mental health.
MECHANISMS OF SUPPORT: Grants of up to $25,000 for individual investigators and $50,000 for collaborative grants will be made, subject to availability of funds. The funding period is for one year. No indirect costs will be paid. ELIGIBILITY: Research performance sites must be in Arizona. Investigators who have received one IMHR grant in the past are eligible to apply for another IMHR grant on a different project; their application must mention the previous grant, its progress to date, and any published works about it. Investigators may receive only two consecutive IMHR grants; after two consecutive grants they must wait one year before applying for another grant.RESEARCH OBJECTIVES: The Institute for Mental Health Research Pilot Study Program is designed to facilitate new research on mental disorders and mental health.
Information obtained from the research should allow for subsequent submission for competitive grant support through other funding agencies or have commercial potential.
Proposals related to IMHR's focus on the understanding, treatment and prevention of mental illness and the promotion and maintenance of mental health from a developmental lifespan perspective--the study of mental illness and health in children, adolescents, adults and later in life--are encouraged. IMHR also encourages, but does not require, the submission of applications for studies of Hispanic and Native American populations.
All proposals must include a preliminary plan and timeline for submission of a competitive grant application to another funding source.The mission of the Institute for Mental Health Research encourages collaboration between institutions. Therefore, in addition to individual grants of $25,000, the Institute will award two $50,000 grants for research that demonstrates collaboration between two or more institutions (e.g., universities or hospitals) within the state of Arizona.Full Application:
1) Completion of the Verification of No Prior Funding form (attached to this announcement or available from IMHR - request at http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:clagesse@imhr.org).
2) A list of 5 names, addresses, phone numbers, and email addresses of suggested reviewers for the application. The suggested reviewers should not work with the applicant and should, preferably, work out of state.
3) The PHS research grant application instructions and forms (rev. 4/2006) at http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=http://grants.nih.gov/grants/funding/phs398/phs398.html must be used in applying for these funds. Applications must include:
a. Face page/Grant Application (form page 1, and page 1-continued if there are multiple investigators)
b. Description, Performance Sites, and Personnel (form page 2)
c. Table of Contents (form page 3)
d. Detailed Budget (form page 4 – budget is limited to $25,000 for an individual grant or $50,000 for a collaborative grant – indirect costs are not allowed)
e. Biographical Sketch(es) for key personnel
f. Resources
g. Checklist
4) Research Plan to include (limited to 5 pages):
a. State whether you are applying for an individual grant of $25,000 or a collaborative grant of $50,000 (collaborative grants must demonstrate collaborative work between at least two mental health research institutions in Arizona).
b. Specific Aims
c. Background and Significance. Clearly state how the research relates to mental health issues
d. Preliminary Studies
e. Research Design and Methods. Make explicit what pilot data will be obtained if requested funds are awarded.
f. Timeline and Plan for Submission of Competitive Grant Application
g. Human Subjects (if applicable)
h. Vertebrate Animals (if applicable)
i. Literature Cited
5) Appendices are limited to two publications, manuscripts, abstracts, patents, or other printed materials directly relevant to the proposal.
SUBMIT APPLICATION: Email the entire application as one file, appendices can be in a separate file in the same email to: http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:Clagesse@imhr.org. Mail the original signed application to:Carol Lagesse, Operations DirectorInstitute for Mental Health Research222 W. Thomas Road, Suite 414Phoenix, AZ 85013
APPLICATION REVIEW CRITERIA: Applications will be reviewed for scientific and technical merit by Internal and External Scientific Advisors. Applications will be rated based on 1) significance, 2) quality, innovation, and feasibility, 3) use of existing facilities, 4) potential of applicant to develop a successful research program in the field, 5) likelihood of leading to a successful grant application from another source or commercial potential, and 6) compatibility with IMHR’s statewide mental health vision and mission. Final award decisions will be made by the Board of Directors of IMHR in January 2008. Notification of Awards will be available no later than January 31, 2008. The expected funding start date of successful applications will be March 3, 2008.
INQUIRIES: Inquiries are encouraged and can be directed to:Carol Lagesse, Operations DirectorInstitute for Mental Health Research222 W. Thomas Road, Suite 414Phoenix, AZ 85013Email: http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:Clagesse@imhr.orgPhone: 602.406.4360
PURPOSE: The Institute for Mental Health Research invites applications for pilot studies to support basic science and clinical research on mental disorders and mental health.
MECHANISMS OF SUPPORT: Grants of up to $25,000 for individual investigators and $50,000 for collaborative grants will be made, subject to availability of funds. The funding period is for one year. No indirect costs will be paid. ELIGIBILITY: Research performance sites must be in Arizona. Investigators who have received one IMHR grant in the past are eligible to apply for another IMHR grant on a different project; their application must mention the previous grant, its progress to date, and any published works about it. Investigators may receive only two consecutive IMHR grants; after two consecutive grants they must wait one year before applying for another grant.RESEARCH OBJECTIVES: The Institute for Mental Health Research Pilot Study Program is designed to facilitate new research on mental disorders and mental health.
Information obtained from the research should allow for subsequent submission for competitive grant support through other funding agencies or have commercial potential.
Proposals related to IMHR's focus on the understanding, treatment and prevention of mental illness and the promotion and maintenance of mental health from a developmental lifespan perspective--the study of mental illness and health in children, adolescents, adults and later in life--are encouraged. IMHR also encourages, but does not require, the submission of applications for studies of Hispanic and Native American populations.
All proposals must include a preliminary plan and timeline for submission of a competitive grant application to another funding source.The mission of the Institute for Mental Health Research encourages collaboration between institutions. Therefore, in addition to individual grants of $25,000, the Institute will award two $50,000 grants for research that demonstrates collaboration between two or more institutions (e.g., universities or hospitals) within the state of Arizona.Full Application:
1) Completion of the Verification of No Prior Funding form (attached to this announcement or available from IMHR - request at http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:clagesse@imhr.org).
2) A list of 5 names, addresses, phone numbers, and email addresses of suggested reviewers for the application. The suggested reviewers should not work with the applicant and should, preferably, work out of state.
3) The PHS research grant application instructions and forms (rev. 4/2006) at http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=http://grants.nih.gov/grants/funding/phs398/phs398.html must be used in applying for these funds. Applications must include:
a. Face page/Grant Application (form page 1, and page 1-continued if there are multiple investigators)
b. Description, Performance Sites, and Personnel (form page 2)
c. Table of Contents (form page 3)
d. Detailed Budget (form page 4 – budget is limited to $25,000 for an individual grant or $50,000 for a collaborative grant – indirect costs are not allowed)
e. Biographical Sketch(es) for key personnel
f. Resources
g. Checklist
4) Research Plan to include (limited to 5 pages):
a. State whether you are applying for an individual grant of $25,000 or a collaborative grant of $50,000 (collaborative grants must demonstrate collaborative work between at least two mental health research institutions in Arizona).
b. Specific Aims
c. Background and Significance. Clearly state how the research relates to mental health issues
d. Preliminary Studies
e. Research Design and Methods. Make explicit what pilot data will be obtained if requested funds are awarded.
f. Timeline and Plan for Submission of Competitive Grant Application
g. Human Subjects (if applicable)
h. Vertebrate Animals (if applicable)
i. Literature Cited
5) Appendices are limited to two publications, manuscripts, abstracts, patents, or other printed materials directly relevant to the proposal.
SUBMIT APPLICATION: Email the entire application as one file, appendices can be in a separate file in the same email to: http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:Clagesse@imhr.org. Mail the original signed application to:Carol Lagesse, Operations DirectorInstitute for Mental Health Research222 W. Thomas Road, Suite 414Phoenix, AZ 85013
APPLICATION REVIEW CRITERIA: Applications will be reviewed for scientific and technical merit by Internal and External Scientific Advisors. Applications will be rated based on 1) significance, 2) quality, innovation, and feasibility, 3) use of existing facilities, 4) potential of applicant to develop a successful research program in the field, 5) likelihood of leading to a successful grant application from another source or commercial potential, and 6) compatibility with IMHR’s statewide mental health vision and mission. Final award decisions will be made by the Board of Directors of IMHR in January 2008. Notification of Awards will be available no later than January 31, 2008. The expected funding start date of successful applications will be March 3, 2008.
INQUIRIES: Inquiries are encouraged and can be directed to:Carol Lagesse, Operations DirectorInstitute for Mental Health Research222 W. Thomas Road, Suite 414Phoenix, AZ 85013Email: http://www.firedrummarketing.com/servlet/clickercount?clientid=00000203&messageid=00001106&memberid=01322706&sendingid=560FBFB751D5&campaignid=00001106&finaldest=mailto:Clagesse@imhr.orgPhone: 602.406.4360
Thursday, July 5, 2007
BioAgriculture Small Business Innovation Research
The purpose of the SBIR program is to provide an opportunity for US-owned, for-profit small business firms to submit innovative, applied, research and development projects that address important problems facing American agriculture and have the potential to lead to significant public benefit if the research is successful. Research proposals are accepted in any of the following topic areas: 1) Forests and Related Resources; 2) Plant Production and Protection - Biology; 3) Animal Production and Protection; 4) Soil and Water Resources; 5) Food Science and Nutrition; 6) Rural Development; 7) Aquaculture; 8) Biofuels and Biobased Products; 9) Marketing and Trade; 10) Animal Manure Management; 11) Small and Mid-Size Farms; and 12) Plant Production and Protection - Engineering. The SBIR program exists in three phases. The purpose of Phase I is to prove the scientific or technical feasibility of the proposed research and development effort. Phase I projects typically are for 8 months. Phase II is the principal research and development effort and often involves moving the project from the laboratory to the field or the development of prototypes. Phase II projects typically are for 24 months. Phase III is the commercialization phase and there is no SBIR support provided for this phase. Phase I applications are due on September 5, 2007. This SBIR program funding opportunity is for Phase I applications.
Link to Full Announcement
Fiscal Year 2008 Small Business Innovation Research Program - Phase I
If you have difficulty accessing the full announcement electronically, please contact:
CSREES Help Desk Phone: 202-401-5048 Business hours are M-F, 7:00 am -5:00 pm ET, excluding Federal holidays If you have any questions related to preparing application content
Link to Full Announcement
Fiscal Year 2008 Small Business Innovation Research Program - Phase I
If you have difficulty accessing the full announcement electronically, please contact:
CSREES Help Desk Phone: 202-401-5048 Business hours are M-F, 7:00 am -5:00 pm ET, excluding Federal holidays If you have any questions related to preparing application content
Monday, July 2, 2007
Reporting DNA-Based Genetic Test Results Applicable to Heritable Conditions and/or Markers of Drug Metabolism
The purpose of this RFA is to solicit applications proposing to develop and pilot test genetic test reports designed to integrate genotypic results pertinent to heritable conditions and/or markers for drug metabolism into a clear and coherent interpretation that effectively communicates clinically important concepts useful for clinical decision making and/or counseling.
Link to Full Announcement
CDC Grant Funding Opportunity Announcements (FOAs)
If you have difficulty accessing the full announcement electronically, please contact:
CDC, Technical Information Management Section Phone 770-488-2700 Procurement and Grants Office, Technical Information Management Section
Link to Full Announcement
CDC Grant Funding Opportunity Announcements (FOAs)
If you have difficulty accessing the full announcement electronically, please contact:
CDC, Technical Information Management Section Phone 770-488-2700 Procurement and Grants Office, Technical Information Management Section
Neurotechnology Research, Development, and Enhancement (SBIR [R43/R44]) and SSTR
Advances in the brain and behavioral sciences are being made rapidly, vastly improving our understanding of healthy brain function and offering promise to the millions suffering from brain and behavioral disorders. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to enable neuroscience and behavioral research through the development of novel, or the significant enhancement or improvement of currently existing, tools and approaches to be used in brain and behavioral research. Such tools and approaches could include those used in basic or clinical research, or for clinical treatment and care (e.g., assessment, diagnosis, and treatment of brain disorders). Research solicited under this funding opportunity announcement is not limited to any particular type of technology, level of analysis, or approach. Multidisciplinary teams of researchers are especially encouraged to apply. Technologies appropriate for study, development and enhancement under this FOA include hardware, software, and wetware (and combinations thereof).
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-389.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-389.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Reducing Health Disparities Among Minority and Underserved Children (R01)
This Funding Opportunity Announcement (FOA) issued by the National Institute of Nursing Research (NINR), National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Alcohol, Alcoholism, and Alcohol Abuse (NIAAA), National Cancer Institute (NCI), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), solicits Research Project Grant (R01) applications from institutions/organizations that propose to conduct research to reduce health disparities among minority and underserved children. Specifically, this initiative focuses on ethnic and racial minority children and underserved populations of children such as: children from low literacy, rural and low-income populations, geographically isolated children, hearing and visually impaired children, physically or mentally disabled children, children of migrant workers, children from immigrant and refugee families, and language minority children. Specific targeted areas of research include biobehavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (physical and family environments), social (e.g., peer influences), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known illness and/or disability; and studies that test and evaluate the cost effectiveness of health promotion interventions conducted in nontraditional settings
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-392.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Link to Full Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-07-392.html
If you have difficulty accessing the full announcement electronically, please contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOVIf you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Subscribe to:
Posts (Atom)